TABLE 1.
Characteristics of 1309 BAN mother-infant pairs in the primary analysis of the effects of maternal weight loss on infant growth1
| Characteristic | Value |
| Mothers | |
| Age, y | 26.7 ± 5.1 |
| Height, cm | 156.9 ± 5.5 |
| Weight, kg | 56.2 ± 8.8 |
| BMI, kg/m2 | 22.8 ± 3.2 |
| Primiparous, % | 9.6 |
| Married, % | 92.3 |
| Education beyond primary school, % | 36.1 |
| Hemoglobin,2 g/L | 109 ± 12 |
| CD4+ count,2 cells/mm3 | 475 ± 196 |
| Low CD4+ count,2,3 % | 29.9 |
| Received ARV intervention, % | 35.8 |
| Received LNS intervention, % | 51.8 |
| Maternal weight change from 2 to 24 wk, kg | −0.93 ± 3.4 |
| Infants | |
| Male gender, % | 51.5 |
| Birth weight, kg | 3.04 ± 0.40 |
| Low birth weight,4 % | 6.0 |
| Birth length, cm | 48.3 ± 1.9 |
| Hemoglobin, g/L | 174 ± 20.1 |
| Received ARV intervention, % | 38.4 |
| Weight gain from birth to 24 wk, kg | 4.13 ± 0.82 |
| Length gain from birth to 24 wk, cm | 15.7 ± 2.2 |
1
Values are means ± SDs or percent. ARV, antiretroviral drug; BAN, Breastfeeding, Antiretrovirals, and Nutrition; LNS, lipid-based nutrient supplement.
2
Measured during pregnancy.
3
Low CD4+ is <350 cells/mm3.
4
Low birth weight is 2–2.5 kg, as infants had to weigh ≥2.0 kg to be eligible for the BAN Study.